The report was based on observational data from China, France, South Korea, Algeria, and the U.S. Of these, 2,137 or 91.6 percent improved clinically.
Source: c19study.com The studies continue to roll out, and there has been very positive results in pre and post exposure as well as early treatment
Source: IC Journal Citation: Hong KS, Jang JG, Hur J, Lee JH, Kim HN, Lee W, Ahn JH. Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory
Source: WND By Elizabeth Lee Vliet, M.D. Stunning positive news on hydroxychloroquine (HCQ) was released in early July, potentially opening up medical freedom at the time of America’s
HCQ use significantly reduced the mortality rate, but this association was found only in the lowest cumulative dosage exposure group.
Source: c19 Study A live and ongoing index of study data from around the world documenting the use of hydroxychloroquine in treatment at various stages
Source: Fox News Researchers at the Henry Ford Health System in Southeast Michigan have found that early administration of the drug hydroxychloroquine makes hospitalized patients substantially
Source: Dr Drew Dr. Vladimir Zelenko, M.D. is a practicing front line family practitioner in New York who has been working in the epicentre of
Source: Detroit News A Henry Ford Health System study shows the controversial anti-malaria drug hydroxychloroquine helps lower the death rate of COVID-19 patients, the Detroit-based health
Source: International Journal of Infectious Diseases Highlights As of May27, 2020 there are over 1,678,843 confirmed cases of COVID-19 claiming more than 100,000 lives in
In this study of over 6000 hospitalized patients with COVID-19 in the New York City, hydroxychloroquine use was associated with decreased mortality.
The UK medicines agency has given the green light to resume a clinical trial of hydroxychloroquine to prevent Covid-19.
Hydroxychloroquine use was associated with decreased mortality.
Our data suggest that chronic treatment with HCQ confer protection against SARS-CoV-2 infection.
The clinical trials on this list are studying Hydroxychloroquine. All trials on the list are supported by NCI.
Origial Source: FranceSoir In the Recovery and Solidarity clinical trials, it is not excluded that patients died as a result of a therapeutic overdose of
Source: Science Direct Background In our institute in Marseille, France, we initiated early and massive screening for coronavirus disease 2019 (COVID-19). Hospitalization and early treatment
Source: BioRxiv The pandemic coronavirus COVID-19 affected global health from the end of 2019 to 2020 and may challenge global health in the future. There
This study provides evidence that (hydroxy)chloroquine may be used effectively in treating moderate COVID-19 and supports larger trials.
This represents a 25% relative increase in the likelihood of being discharged from hospital, the study said.
Conclusions: In subjects free of COVID-19, we found a small increase in QTc associated with use of chloroquine, but not hydroxychloroquine. We found no increased mortality associated with use of hydroxychloroquine.
Source: Spectator Big Pharma laughs all the way to the bank. The Fawlty Towers episode ’Don’t Mention the War’ has been banned by the BBC but a
Significantly higher rates of discharge home were observed in patients treated by HCQ, a novel finding warranting further confirmation in replicative studies.
How can we trust the established authorities or prestigious journals when, in this perilous time, trials of an available, inexpensive, long-established drug appear to be designed to fail, while risking the lives of their subjects through deliberate or negligent drug overdoses?
The hydroxychloroquine (HCQ) arm of the trials had been stopped after publication of the Lancet Surgisphere study, which claimed that patients who received hydroxychloroquine had 35% higher death rates, but the Lancet study was retracted 13 days after publication, as its data turned out to be fabricated.
The study, which was obviously flawed on its face (I commented well before it was exposed that the groupings made no sense), turned out to be produced by a shell company, with unverified data gathered by non-scientists.
India’s ICMR, its official medical research agency, had written to the WHO, telling WHO that the hydroxychloroquine doses being used in the Solidarity trial were 4 times higher than the doses being used in India.
None of the patients died in the studied period and only 6 have to be admitted in conventional hospitalization area.
Source: MedRxiv Abstract: The new SARS-CoV-2 infection named COVID-19 has severely hit our Health System. At the time of writing this paper no medical therapy
Source: MedRxiv Abstract Background: While several trials are ongoing for treatment of COVID-19, scientific research on chemoprophylaxis is still lacking even though it has potential
Source: Jakarta Globe Researchers from Airlangga University, Government’s Covid-19 Task Force, and State Intelligence Agency (BIN) have claimed to have found combinations of medicine that effectively reduce the
Source: The Guardian Questions continue for Surgisphere and CEO Sapan Desai as universities deny knowledge of links to firm behind Lancet’s now-disputed blockbuster study. Dozens
Source:Israel National News Two controversial coronavirus studies retracted after authors failed to show data was reliable. “Lancet and the BMJ did not do its due
Source: Pan American Health Organisation Importance: Patients in long-term care facilities (LTCF) are at a high-risk of contracting COVID-19 due to advanced age and multiple
Source: ScienceDirect | PDF of full Journal Pre-Print Abstract In the context of the current COVID-19 pandemic, we conducted a meta-analysis on the effects of
Source: Indian Express In a statement, The Lancet said that “important scientific questions” were raised about data in the paper authored by cardiologist Mandeep Mehra,
Source: statnews The World Health Organization is resuming a clinical trial exploring whether the malaria drug hydroxychloroquine can effectively treat Covid-19, after pausing enrollment in
Hydroxychloroquine alone is not the whole story. It needs to be combined with azithromycin and zinc.
Source: Medrxiv View ORCID Profile Amanda Chamieh, Claude Afif, View ORCID Profile Gerard El-Hajj, View ORCID Profile Omar Zmerli, Isabelle Djaffar-Jureidini,View ORCID Profile Roy A. Raad, Raja Ashou, George Juvelekian,View ORCID Profile Jean-Marc Rolain,View ORCID Profile Eid Azar doi: https://doi.org/10.1101/2020.05.28.20114835 This article
Source: Global Research A few years ago the British medical journal, The Lancet, published a paper touting the safety of HCQ. But this was before HCQ
